Indian researchers are planning to develop an AIDS vaccine by isolating and studying naturally neutralising antibodies from HIV patients in the country.

Around to three to four per cent of people do not develop the disease for many years in spite of being infected with HIV. This was because they have naturally neutralising antibodies. “We are trying to isolate those anti-bodies and use that information to develop a vaccine,” Dr. Jayanta Bhattacharya, Principal Investigator, R & D, International AIDS Vaccine Initiative (IAVI), India said.

Talking to The Hindu on the sidelines of a Vaccine Summit here on Wednesday, who is working at IAVI’s Translational Health Science & Technology, Institute, Gurgaon, said the technology was in place and within a year the anti-bodies would be isolated from Indian HIV carriers.

Dr. Jayanta Bhattacharyasaid they were also studying the structure of the outer protein coat of HIV in a bid to block it from interacting with CD4 receptors.